169 related articles for article (PubMed ID: 3076140)
21. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
Weisser B; Gerwe M; Braun M; Funken C
Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
[TBL] [Abstract][Full Text] [Related]
22. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
[TBL] [Abstract][Full Text] [Related]
23. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
24. Comparative trial of pinacidil versus prazosin in mild to moderate arterial hypertension.
Sterndorff B; Johansen P
Drugs; 1988; 36 Suppl 7():64-6. PubMed ID: 3076137
[No Abstract] [Full Text] [Related]
25. Clinical pharmacology of pinacidil, a prototype for drugs that affect potassium channels.
Goldberg MR
J Cardiovasc Pharmacol; 1988; 12 Suppl 2():S41-7. PubMed ID: 2466178
[TBL] [Abstract][Full Text] [Related]
26. Felodipine versus Moduretic. A double-blind parallel-group multicentre study.
Krönig B; Flygt G
Drugs; 1987; 34 Suppl 3():162-9. PubMed ID: 3327677
[TBL] [Abstract][Full Text] [Related]
27. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.
Frishman WH; Zawada ET; Smith LK; Sowers J; Swartz SL; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H
Am J Cardiol; 1987 Mar; 59(6):615-23. PubMed ID: 3548301
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of valsartan/hydrochlorothiazide fixed-dose combination compared with amlodipine monotherapy as first-line therapy for mild to moderate hypertension.
Chao CL; Lin YH; Lin LC; Lin LY; Tsai CT; Wang YC; Hwang JJ; Chen JC; Chiang FT
J Int Med Res; 2009; 37(2):289-97. PubMed ID: 19383221
[TBL] [Abstract][Full Text] [Related]
29. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
[TBL] [Abstract][Full Text] [Related]
30. Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertension.
Muiesan G; Fariello R; Muiesan ML; Christensen OE
Eur J Clin Pharmacol; 1985; 28(5):495-9. PubMed ID: 3899669
[TBL] [Abstract][Full Text] [Related]
31. Pinacidil monotherapy for hypertension.
Ward JW
Br J Clin Pharmacol; 1984 Aug; 18(2):223-5. PubMed ID: 6487460
[TBL] [Abstract][Full Text] [Related]
32. Preliminary evaluation of pinacidil in hypertension.
Ramsay LE; Freestone S
Br J Clin Pharmacol; 1983 Sep; 16(3):336-8. PubMed ID: 6626426
[TBL] [Abstract][Full Text] [Related]
33. Felodipine in hypertensive patients. A dose finding study in patients refractory to beta-blocker monotherapy.
Sluiter HE
Drugs; 1987; 34 Suppl 3():97-106. PubMed ID: 2894980
[TBL] [Abstract][Full Text] [Related]
34. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
Jackson B; Morgan TO; Gibson J; Anderson A
Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
[TBL] [Abstract][Full Text] [Related]
35. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide.
Frishman WH; Bryzinski BS; Coulson LR; DeQuattro VL; Vlachakis ND; Mroczek WJ; Dukart G; Goldberg JD; Alemayehu D; Koury K
Arch Intern Med; 1994 Jul; 154(13):1461-8. PubMed ID: 8018001
[TBL] [Abstract][Full Text] [Related]
36. Comparative trials of terazosin with other antihypertensive agents.
Ruoff G
Am J Med; 1986 May; 80(5B):42-8. PubMed ID: 2872806
[TBL] [Abstract][Full Text] [Related]
37. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
38. Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension.
Frishman WH; Goldberger J; Sherman D
J Clin Hypertens; 1987 Dec; 3(4):520-7. PubMed ID: 2839628
[TBL] [Abstract][Full Text] [Related]
39. Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study.
Materson BJ; Cushman WC; Goldstein G; Reda DJ; Freis ED; Ramirez EA; Talmers FN; White TJ; Nunn S; Chapman RH
Hypertension; 1990 Apr; 15(4):348-60. PubMed ID: 2318517
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
